The National Cancer Institute is offering SBIR Phase IIB Bridge Awards to small businesses for the development of cancer therapeutics, imaging technologies, diagnostics, and prognostics. This grant aims to support projects that have previously received Phase II funding from Federal agencies and assist in transitioning them to the commercialization stage. Emphasis is placed on fostering partnerships with third-party investors to facilitate the necessary steps for product commercialization. Projects may encompass preclinical and clinical technology development, with a focus on cancer relevance. A Commercialization Plan including details on third-party investor funding is required for submission. Clinical trials are optional. Closing date for applications is August 9, 2019.
Opportunity ID: 314627
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-19-047 |
| Funding Opportunity Title: | SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 08, 2019 |
| Last Updated Date: | Apr 08, 2019 |
| Original Closing Date for Applications: | Aug 09, 2019 |
| Current Closing Date for Applications: | Aug 09, 2019 |
| Archive Date: | Sep 14, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding announcement for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices, and/or in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics. The purpose of this FOA is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services. Applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-047.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | FORMS-E | PKG00249807 | Jul 09, 2019 | Aug 09, 2019 | View |
Package 1
Mandatory forms
314627 RR_SF424_2_0-2.0.pdf
314627 PHS398_CoverPageSupplement_4_0-4.0.pdf
314627 RR_OtherProjectInfo_1_4-1.4.pdf
314627 PerformanceSite_2_0-2.0.pdf
314627 RR_KeyPersonExpanded_2_0-2.0.pdf
314627 RR_Budget_1_4-1.4.pdf
314627 PHS398_ResearchPlan_4_0-4.0.pdf
314627 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
314627 RR_SubawardBudget30_1_4-1.4.pdf
314627 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
